All Pathways
Hematology & OncologyEmergency

Massive Transfusion Protocol (AAST/ACS 2024)

Massive Transfusion Protocol (AAST/ACS 2024): Hemorrhagic Shock → MTP Activation Criteria → ACTIVATE MTP → Initial Resuscitation → Tranexamic Acid.

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Hemorrhagic Shock

    Patient with significant hemorrhage or anticipated massive transfusion

    1. Decision

      MTP Activation Criteria

      Assess need for massive transfusion

      • ABC Score ≥2 or Clinical judgment
      • Penetrating trauma + SBP ≤90 + HR ≥120
      • Anticipated need for >10 units PRBCs in 24h
      • Unstable despite 2L crystalloid
      • Active hemorrhage with shock
      1. Warning

        ACTIVATE MTP

        Call blood bank, mobilize team

        • Call blood bank with patient identifier
        • Request MTP cooler (typically 6:6:1 or 4:4:1)
        • Notify surgical/trauma team
        • Prepare for OR if surgical source
        1. Action

          Initial Resuscitation

          Balanced blood product administration

          • 1:1:1 ratio (or close): RBC:Plasma:Platelets
          • Whole blood if available (preferred)
          • Use rapid infuser/blood warmer
          • Permissive hypotension (SBP 80-90) until surgical control
          • Avoid crystalloid boluses
          1. Action

            Tranexamic Acid

            Give within 3 hours of injury

            • 1g IV bolus over 10 min
            • Then 1g IV over 8 hours
            • Most benefit if given <1 hour
            1. Decision

              TEG/ROTEM Available?

              Viscoelastic testing for goal-directed therapy

              1. Action

                TEG/ROTEM-Guided Therapy

                Target specific deficiencies

                • Prolonged R/CT: Give plasma
                • Low MA/MCF: Give platelets
                • Low fibrinogen/α-angle: Give cryoprecipitate
                • Fibrinolysis: Consider additional TXA
                1. Decision

                  Hemorrhage Controlled?

                  Surgical or interventional control achieved

                  1. Action

                    Continue MTP

                    Ongoing hemorrhage

                    • Continue product administration
                    • Urgent surgical control
                    • Consider interventional radiology
                    • REBOA if indicated
                  2. Action

                    Deactivate MTP

                    Hemorrhage controlled

                    • Notify blood bank to stop coolers
                    • Return unused products
                    • Continue monitoring/correcting coagulopathy
                    • Prevent/treat hypothermia and acidosis
                    1. Outcome

                      Patient Stabilized

                      Hemorrhage controlled, coagulopathy corrected

              2. Action

                Continue 1:1:1 Empirically

                Without TEG, maintain balanced resuscitation

                • Continue 1:1:1 ratio
                • Check labs q30-60min: CBC, PT/PTT, fibrinogen
                • Target: Plt >50, INR <1.5, Fib >1.5 g/L
          2. Action

            Calcium Replacement

            Counter citrate toxicity

            • Calcium chloride 1g IV per 4 units blood
            • Or calcium gluconate 2-3g
            • Target iCa >1.0 mmol/L
            • Monitor with each cooler

Guideline Source

AAST/ACS Clinical Protocol for Damage-Control Resuscitation

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Trigger criteria vary by institution
  • Blood product availability may limit implementation
  • Does not replace surgical hemorrhage control
  • TEG/ROTEM interpretation requires training

Applicable Regions

USEUGlobal

EU: Component therapy ratios may vary by center

US: Whole blood increasingly available at trauma centers

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Massive Transfusion Protocol (AAST/ACS 2024)?

The Massive Transfusion Protocol (AAST/ACS 2024) is a emergency clinical algorithm for Hematology & Oncology. It provides a structured decision tree to guide clinical decision-making, based on AAST/ACS Clinical Protocol for Damage-Control Resuscitation.

What guideline is the Massive Transfusion Protocol (AAST/ACS 2024) based on?

This algorithm is based on AAST/ACS Clinical Protocol for Damage-Control Resuscitation (DOI: 10.1097/TA.0000000000004088).

What are the limitations of the Massive Transfusion Protocol (AAST/ACS 2024)?

Known limitations include: Trigger criteria vary by institution; Blood product availability may limit implementation; Does not replace surgical hemorrhage control; TEG/ROTEM interpretation requires training. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Massive Transfusion Protocol (AAST/ACS 2024) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free